Vaccinex
A clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases. Learn more
Launch date
Employees
Market cap
€8.8m
Enterprise valuation
€10m (Public information from Sep 2024)
Share price
$5.16 VCNX
Rochester New York (HQ)
Authorizing premium user...